Pinnacle Associates Ltd

SEC CIK: 0000743127
Latest filing: Aug 3, 2026

SEC filings (opens in a new tab)

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Pinnacle Associates Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overview All 13F holders of REGN Full Q2 2026 holdings

Shares (Q2 2026): 81,247
Value: $50.7M
% of portfolio: 0.6%
Quarters held: 22; Since Q1 2021

Holdings of REGN by Pinnacle Associates Ltd, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	81,247	$50.7M	0.6%	−1,265−1.5%	Reduced	Holders
Q1 2026	82,512	$63.8M	0.8%	−1,229−1.5%	Reduced	Holders
Q4 2025	83,741	$64.6M	0.8%	−450−0.5%	Reduced	Holders
Q3 2025	84,191	$47.3M	0.6%	+15,265+22.1%	Added	Holders
Q2 2025	68,926	$36.2M	0.5%	−12,087−14.9%	Reduced	Holders
Q1 2025	81,013	$51.4M	0.8%	+18,550+29.7%	Added	Holders
Q4 2024	62,463	$44.5M	0.6%	−4,502−6.7%	Reduced	Holders
Q3 2024	66,965	$58.8M	1.0%	+611+0.9%	Added	Holders
Q2 2024	66,354	$69.7M	1.1%	−156−0.2%	Reduced	Holders
Q1 2024	66,510	$64.0M	1.0%	−455−0.7%	Reduced	Holders
Q4 2023	66,965	$58.8M	1.0%	−518−0.8%	Reduced	Holders
Q3 2023	67,483	$55.5M	1.0%	−2,712−3.9%	Reduced	Holders
Q2 2023	70,195	$50.4M	0.9%	−1,504−2.1%	Reduced	Holders
Q1 2023	71,699	$58.9M	1.2%	−1,291−1.8%	Reduced	Holders
Q4 2022	72,990	$52.7M	1.1%	−527−0.7%	Reduced	Holders
Q3 2022	73,517	$50.6M	1.2%	−15,171−17.1%	Reduced	Holders
Q2 2022	88,688	$52.4M	1.1%	−3,013−3.3%	Reduced	Holders
Q1 2022	91,701	$64.0M	1.1%	−3,794−4.0%	Reduced	Holders
Q4 2021	95,495	$60.3M	1.0%	−1,424−1.5%	Reduced	Holders
Q3 2021	96,919	$58.7M	1.1%	−2,462−2.5%	Reduced	Holders
Q2 2021	99,381	$55.5M	1.0%	−1,110−1.1%	Reduced	Holders
Q1 2021	100,491	$47.5M	0.9%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.